LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart

Ronny Alcalai1,2, Michael Arad3, Hiroko Wakimoto2

  • 1Heart InstituteHadassah Hebrew University Medical Center Jerusalem Israel.

Insights

A LAMP2 gene mutation causes Danon disease cardiomyopathy in mice, leading to heart failure, arrhythmias, and cellular damage due to impaired autophagy.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Human mutations in the X-linked lysosome-associated membrane protein-2 (LAMP2) gene cause Danon disease, a condition characterized by cardiac hypertrophy, conduction abnormalities, and arrhythmias.
  • A specific in-frame exon 6 deletion (L2Δ6) in the LAMP2 gene is linked to human cardiomyopathy.

Purpose of the Study:

  • To investigate the consequences of the L2Δ6 mutation on cardiomyocyte biology and cardiac function in a mouse model.
  • To elucidate the molecular mechanisms underlying LAMP2-associated cardiomyopathy.

Main Methods:

  • Introduction of an in-frame LAMP2 exon 6 deletion mutation into the mouse LAMP2 gene.
  • Analysis of cardiac function, electrophysiology, and cardiomyocyte biology in mutant (L2Δ6) and wild-type mice.
  • Utilized immunofluorescence, transmission electron microscopy, and gene/protein expression analyses.

Main Results:

  • L2Δ6 mice exhibited reduced LAMP2 protein levels despite equivalent LAMP2 RNA.
  • Mutant mice developed progressive left ventricular hypertrophy, dilatation, reduced systolic function, arrhythmias, and fibrosis.
  • Cellular analysis revealed lysosomal mislocalization, autophagosome accumulation, and disrupted ultrastructure.

Conclusions:

  • Impaired autophagy is a key factor in L2Δ6-induced cardiac hypertrophy and dysfunction.
  • Transcriptional changes impact metabolism, calcium homeostasis, and cell survival, defining pathways in Danon disease cardiomyopathy.
  • The L2Δ6 mouse model effectively recapitulates human LAMP2 cardiomyopathy, offering insights into disease mechanisms.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
97
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.9K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
84
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
108
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
131